Q BioMed Cash from Financing (TTM) Trends

Q BioMed Inc (QBIO)

0.00 USD | OTCM | May 16, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
February 28, 2023	0.8491M
November 30, 2022	0.9078M
August 31, 2022	2.273M
May 31, 2022	2.624M
February 28, 2022	3.564M
November 30, 2021	4.469M
August 31, 2021	3.039M
May 31, 2021	2.338M
February 28, 2021	5.348M
November 30, 2020	6.238M
August 31, 2020	6.815M
May 31, 2020	7.428M
February 29, 2020	3.558M
November 30, 2019	1.593M
August 31, 2019	4.558M
May 31, 2019	3.946M

Date	Value
February 28, 2019	3.865M
November 30, 2018	8.810M
August 31, 2018	4.932M
May 31, 2018	7.316M
February 28, 2018	9.816M
November 30, 2017	4.940M
August 31, 2017	6.961M
May 31, 2017	4.833M
February 28, 2017	2.498M
November 30, 2016	2.883M
August 31, 2016	1.085M
May 31, 2016	0.8302M
February 29, 2016	0.6652M
November 30, 2015	0.2102M
August 31, 2015	0.0002M
May 31, 2015	0.025M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.8491M

Minimum

Feb 2023

7.428M

Maximum

May 2020

3.722M

Average

3.561M

Median

Cash from Financing (TTM) Benchmarks